Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹22,063 Cr
Revenue (TTM)
₹2,482 Cr
Net Profit (TTM)
₹854 Cr
ROE
19.6 %
ROCE
26.2 %
P/E Ratio
25.8
P/B Ratio
5.5
Industry P/E
28.7
EV/EBITDA
17.8
Div. Yield
3.4 %
Debt to Equity
0
Book Value
₹872.2
EPS
₹166.6
Face value
10
Shares outstanding
45,747,732
CFO
₹3,793.77 Cr
EBITDA
₹6,154.93 Cr
Net Profit
₹4,993.04 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Pfizer
| -3.4 | -4.6 | -4.8 | 17.7 | 10.6 | 1.4 | 11.2 |
|
BSE Healthcare
| -1.7 | -1.1 | -1.9 | 7.5 | 25.6 | 15.6 | 10.7 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Pfizer
| -6.0 | 23.8 | -3.7 | -12.3 | -4.2 | 20.7 | 47.1 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Pfizer
|
4,818.0 | 22,063.4 | 2,482.3 | 853.6 | 33.7 | 18.9 | 25.8 | 5.5 |
| 3,056.6 | 38,176.6 | 5,201.6 | 1,014.6 | 22.9 | 25 | 37.6 | 8.3 | |
| 8,483.5 | 21,239.3 | 2,177.5 | 200.9 | 11.3 | 26.5 | 105.7 | 25.5 | |
| 1,648.2 | 12,536.2 | 2,089.5 | 622.0 | 31.3 | 20.4 | 20.4 | 3.8 | |
| 1,631.1 | 9,972.2 | 1,196.4 | 149.4 | -- | 27.5 | 66.7 | 14.2 | |
| 1,308.1 | 18,156.7 | 3,078.2 | 469.4 | 26.4 | 14.9 | 42.1 | 5.0 | |
| 2,118.0 | 33,968.6 | 4,193.0 | 753.8 | 22.7 | 20.8 | 45.1 | 8.5 | |
| 4,939.8 | 8,194.5 | 1,348.5 | 293.5 | 28.1 | 50.7 | 27.9 | 11.8 | |
| 3,460.8 | 7,974.5 | 1,837.4 | 326.7 | 24.7 | 45.3 | 24.4 | 10.6 | |
| 907.1 | 8,342.6 | 4,725.6 | 528.7 | 14.9 | 20.7 | 16.3 | 2.8 |
3 min read•By Markets Desk
3 min read•By Research Desk
2 min read•By Research Desk
Diversified Equity Funds: Not Dead Yet
4 min read•By Research Desk
Pfizer Limited engages in manufacturing, marketing, trading, and export of pharmaceutical products in India and internationally. The company offers its products in various therapeutic areas, including neuro/central nervous system, hormones,... cardiovascular, hemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastro intestinal, vaccines, respiratory, and vitamins/minerals/nutrients. It sells its products through a network of independent distributors primarily under various brand names. The company was incorporated in 1950 and is headquartered in Mumbai, India. Read more
Incorporated
1950
Chairman
Pradip Shah
Managing Director
Meenakshi Nevatia
Group
Pfizer - MNC
Headquarters
Mumbai, Maharashtra
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View Announcements
The share price of Pfizer Ltd is ₹4,818.00 (NSE) and ₹4,822.85 (BSE) as of 18-Mar-2026 IST. Pfizer Ltd has given a return of 10.61% in the last 3 years.
The P/E ratio of Pfizer Ltd is 25.85 times as on 18-Mar-2026, a 10 discount to its peers’ median range of 28.70 times.
The P/B ratio of Pfizer Ltd is 5.53 times as on 18-Mar-2026, a 21 premium to its peers’ median range of 4.57 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
23.86
|
4.34
|
|
2024
|
34.80
|
5.34
|
|
2023
|
25.40
|
4.94
|
|
2022
|
32.50
|
6.95
|
|
2021
|
41.57
|
8.64
|
The 52-week high and low of Pfizer Ltd are Rs 5,993.00 and Rs 3,701.00 as of 19-Mar-2026.
Pfizer Ltd has a market capitalisation of ₹ 22,063 Cr as on 18-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Pfizer Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹92.50
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.